Nutritional Buffer Composition for Amino Acid Palatability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Nutritional products containing amino acids like N-acetyl-cysteine and glycine often have unpleasant tastes, which can lead to poor patient compliance due to their acidic, astringent, or sulfury flavors, making it difficult to administer them orally in a palatable form.

Innovation Solution

A nutritional product comprising a buffer composition that adjusts the pH to a range of 3.7 to 7.5, preferably 4.2 to 6.5, using sodium carbonate, potassium carbonate, sodium hydroxide, or potassium hydroxide, significantly reduces the perceived sourness and unpleasant taste, thereby improving palatability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If amino acids like N-acetyl-cysteine and glycine are used in nutritional products, then therapeutic value and health benefits are improved, but unpleasant taste and poor palatability worsen

Engineering Contradiction:
Improvetherapeutic valueVSAvoidpalatability
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

A buffering agent is introduced as an intermediary substance to modify the pH environment of the nutritional product. This mediator interacts with the acidic amino acids to reduce their sour taste perception, allowing the therapeutic benefits of the amino acids to be preserved while significantly improving palatability and patient compliance

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The pH parameter of the nutritional product is deliberately changed by adding buffering agents to achieve a pH range of 3.7-7.5. This parameter modification transforms the taste profile of the amino acids, reducing unpleasant sourness and astringency while maintaining the therapeutic efficacy of the active ingredients

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If buffering agent is added to improve palatability, then patient compliance is improved, but product complexity increases

Engineering Contradiction:
Improvepatient complianceVSAvoidproduct complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

Rather than adding multiple complex components, the solution focuses on modifying a single key parameter (pH) through the addition of buffering agents. This approach improves patient compliance while maintaining relatively simple product formulation and manufacturing processes

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The buffering process effectively masks the undesirable taste of amino acids, enhancing patient compliance and therapeutic value by making the product more palatable and easier to consume.

Implementation Method 1

A nutritional product comprising a buffer composition, an amino acid and optionally a vitamin and/or a mineral. The buffer composition adjusts the pH to a range of 3.7 to 7.5, preferably 4.2 to 6.5

Methodology Applied
Scientific EffectBuffering:

Data Source

PatentUS20230180811A1A nutritional product containing a buffer composition and an amino acid and methods of using such a nutritional product
Publication Date: 2023.06.15 SOCIETE DES PRODUITS NESTLE SA
  • US20230180811A1 patent drawing
  • US20230180811A1 patent drawing
  • US20230180811A1 patent drawing

AI summary

A nutritional product having a pH from about 3.7 to about 7.5, preferably from about 4.2 to about 6.5 includes a buffer composition and an amino acid dissolved in a liquid, and the amino acid is present in an amount that at least partially includes the amino acid in at least one of free form, dipeptides, or tripeptides. The amino acid can include a combination of at least one N-acetyl-cysteine or functional derivative thereof and at least one glycine or functional derivative thereof. The buffer composition may include at least one of sodium bicarbonate, potassium bicarbonate, sodium hydroxide, or potassium hydroxide. The sodium bicarbonate and the potassium bicarbonate can be present in a molar ratio from about 1:1 to about 10:1.